Jump To Section:

Identification Taxonomy Ontology Physical properties Spectra Biological properties Concentrations Links References XML

Show more...Show more...Show more...Show more...Show more...

Record Information

Version

5.0

Status

Expected but not Quantified

Creation Date

2012-09-13 11:50:25 UTC

Update Date

2023-02-21 17:29:05 UTC

HMDB ID

HMDB0041965

Secondary Accession Numbers

HMDB41965

Metabolite Identification

Common Name

O-Toluidine

Description

The chemical properties of the toluidines are quite similar to those of aniline and toluidines have properties in common with other aromatic amines. Due to the amino group bonded to the aromatic ring, the toluidines are weakly basic. None of the toluidines is very soluble in pure water, but will become soluble if the aqueous solution is acidic due to formation of ammonium salts, as usual for organic amines. At room temperature and pressure, ortho- and meta-toluidines are viscous liquids, but para-toluidine is a flaky solid. This can be explained by the fact that the p-toluidine molecules are more symmetrical and fit into a crystalline structure more easily. p-Toluidine can be obtained from reduction of p-nitrotoluene. p-Toluidine reacts with formaldehyde to form Troger's base.

Structure

MOL 3D MOL SDF 3D SDF PDB 3D PDB SMILES InChI

View in JSmol View NMR Assignments View Stereo Labels

Synonyms

Value	Source
1-Amino-2-methylbenzene	ChEBI
1-Methyl-2-aminobenzene	ChEBI
2-Amino-1-methylbenzene	ChEBI
2-Aminotoluene	ChEBI
2-Methyl-1-aminobenzene	ChEBI
2-Methylbenzamine	ChEBI
2-Methylbenzenamine	ChEBI
2-Toluidine	ChEBI
O-Aminotoluene	ChEBI
O-Methylaniline	ChEBI
O-Methylbenzenamine	ChEBI
O-Tolylamine	ChEBI
2-Methyl-aniline	HMDB
2-Methyl-benzenamine	HMDB
2-Methylaniline	HMDB, MeSH
2-Methylphenylamine (acd/name 4.0)	HMDB
O-Toluide	HMDB
O-Toluidin	HMDB
O-Toluidine (acd/name 4.0)	HMDB
O-Toluidyna	HMDB
ortho-Toluidine	HMDB, MeSH
Rcra waste number u328	HMDB
2-Toluidine sulfate	MeSH
2-Toluidine hydrochloride	MeSH
2-Toluidine perchlorate	MeSH
2-Toluidine, (ar)-isomer	MeSH
2-Toluidine, lithium salt	MeSH

Chemical Formula

C₇H₉N

Average Molecular Weight

107.1531

Monoisotopic Molecular Weight

107.073499293

IUPAC Name

2-methylaniline

Traditional Name

toluidine

CAS Registry Number

95-53-4

SMILES

CC1=CC=CC=C1N

InChI Identifier

InChI=1S/C7H9N/c1-6-4-2-3-5-7(6)8/h2-5H,8H2,1H3

InChI Key

RNVCVTLRINQCPJ-UHFFFAOYSA-N

Chemical Taxonomy

Description

Belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group.

Kingdom

Organic compounds

Super Class

Benzenoids

Class

Benzene and substituted derivatives

Sub Class

Toluenes

Direct Parent

Aminotoluenes

Alternative Parents

Substituents

Aminotoluene
Aniline or substituted anilines
Organic nitrogen compound
Organopnictogen compound
Hydrocarbon derivative
Primary amine
Organonitrogen compound
Amine
Aromatic homomonocyclic compound

Molecular Framework

Aromatic homomonocyclic compounds

External Descriptors

aminotoluene (CHEBI:66892 )

Ontology

Physiological effect

Health effect

Cancer

Cancer (HMDB: HMDB0041965)

Disposition

Biological location

Cellular substructure

Cytoplasm (HMDB: HMDB0041965)
Extracellular (HMDB: HMDB0041965)

Source

Exogenous

Exogenous (HMDB: HMDB0041965)

Environmental

Tobacco Smoke (HMDB: HMDB0041965)

Not Available

Indirect biological role

Carcinogen (HMDB: HMDB0041965)

Environmental role

Air pollutant (HMDB: HMDB0041965)

Biological role

Carcinogenic agent (HMDB: HMDB0041965)
Nutrient (HMDB: HMDB0041965)

Physical Properties

State

Liquid

Experimental Molecular Properties

Property	Value	Reference
Melting Point	-16.3 °C	Not Available
Boiling Point	Not Available	Not Available
Water Solubility	16.6 mg/mL at 25 °C	Not Available
LogP	1.32	Not Available

Experimental Chromatographic Properties

Not Available

Predicted Molecular Properties

Property	Value	Source
Water Solubility	10.8 g/L	ALOGPS
logP	1.32	ALOGPS
logP	1.66	ChemAxon
logS	-1	ALOGPS
pKa (Strongest Basic)	4.48	ChemAxon
Physiological Charge	0	ChemAxon
Hydrogen Acceptor Count	1	ChemAxon
Hydrogen Donor Count	1	ChemAxon
Polar Surface Area	26.02 Å²	ChemAxon
Rotatable Bond Count	0	ChemAxon
Refractivity	35.8 m³·mol⁻¹	ChemAxon
Polarizability	12.29 Å³	ChemAxon
Number of Rings	1	ChemAxon
Bioavailability	Yes	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	Yes	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted Chromatographic Properties

Predicted Collision Cross Sections

Predictor	Adduct Type	CCS Value (Å²)	Reference
DarkChem	[M+H]+	120.281	31661259
DarkChem	[M-H]-	116.695	31661259
DeepCCS	[M+H]+	125.06	30932474
DeepCCS	[M-H]-	123.013	30932474
DeepCCS	[M-2H]-	158.833	30932474
DeepCCS	[M+Na]+	133.526	30932474
AllCCS	[M+H]+	119.9	32859911
AllCCS	[M+H-H2O]+	114.9	32859911
AllCCS	[M+NH4]+	124.7	32859911
AllCCS	[M+Na]+	126.0	32859911
AllCCS	[M-H]-	119.6	32859911
AllCCS	[M+Na-2H]-	122.2	32859911
AllCCS	[M+HCOO]-	125.0	32859911

Predicted Kovats Retention Indices

Underivatized

Metabolite	SMILES	Kovats RI Value	Column Type	Reference
O-Toluidine	CC1=CC=CC=C1N	1776.2	Standard polar	33892256
O-Toluidine	CC1=CC=CC=C1N	1042.3	Standard non polar	33892256
O-Toluidine	CC1=CC=CC=C1N	1063.4	Semi standard non polar	33892256

Derivatized

Derivative Name / Structure	SMILES	Kovats RI Value	Column Type	Reference
O-Toluidine,1TMS,isomer #1	CC1=CC=CC=C1N[Si](C)(C)C	1228.9	Semi standard non polar	33892256
O-Toluidine,1TMS,isomer #1	CC1=CC=CC=C1N[Si](C)(C)C	1232.7	Standard non polar	33892256
O-Toluidine,2TMS,isomer #1	CC1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C	1288.4	Semi standard non polar	33892256
O-Toluidine,2TMS,isomer #1	CC1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C	1389.3	Standard non polar	33892256
O-Toluidine,1TBDMS,isomer #1	CC1=CC=CC=C1N[Si](C)(C)C(C)(C)C	1481.8	Semi standard non polar	33892256
O-Toluidine,1TBDMS,isomer #1	CC1=CC=CC=C1N[Si](C)(C)C(C)(C)C	1446.3	Standard non polar	33892256
O-Toluidine,2TBDMS,isomer #1	CC1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	1714.2	Semi standard non polar	33892256
O-Toluidine,2TBDMS,isomer #1	CC1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C	1794.4	Standard non polar	33892256

Spectra

GC-MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Experimental GC-MS	GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized)	splash10-0a4i-5900000000-ee7fe6869533a6858f94	2017-09-12	HMDB team, MONA, MassBank	View Spectrum
Experimental GC-MS	GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized)	splash10-0a4i-6900000000-68480e71423ffd272f9d	2017-09-12	HMDB team, MONA, MassBank	View Spectrum
Experimental GC-MS	GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized)	splash10-0a4i-5900000000-ee7fe6869533a6858f94	2018-05-18	HMDB team, MONA, MassBank	View Spectrum
Experimental GC-MS	GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized)	splash10-0a4i-6900000000-68480e71423ffd272f9d	2018-05-18	HMDB team, MONA, MassBank	View Spectrum
Predicted GC-MS	Predicted GC-MS Spectrum - O-Toluidine GC-MS (Non-derivatized) - 70eV, Positive	splash10-0a4i-7900000000-661d661a8df390a5081a	2017-09-01	Wishart Lab	View Spectrum
Predicted GC-MS	Predicted GC-MS Spectrum - O-Toluidine GC-MS (Non-derivatized) - 70eV, Positive	Not Available	2021-10-12	Wishart Lab	View Spectrum
MS	Mass Spectrum (Electron Ionization)	splash10-0a4i-5900000000-f04208345695340d7d9f	2014-09-20	Not Available	View Spectrum

MS/MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-052f-9500000000-1da8fd338a6e499f67b8	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-e311b1811a6d3a59268a	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-1c57a6134b99aef82338	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-1843caa3f26f243817eb	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-e44d3c280fede3615b13	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0a4i-0900000000-3cd853f6114cba521a13	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0a4i-0900000000-b4d6fdb227e5b9621611	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0a4i-2900000000-2f6e21711a72ca0477a8	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0a4l-7900000000-c0f650fc70669757d0e6	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9400000000-bcd0a7b786b0217f655c	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9100000000-4312ff484c74be498895	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-4e34b2af3ed0df18b3b2	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-0006-9000000000-8facfe25a950827aa822	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF	splash10-00kf-9000000000-978c9096a7e167a13bc3	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF	splash10-0006-9000000000-59dad1d5d1802381bc6a	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF	splash10-0006-9000000000-31d6e4c02cb1c35d7e2d	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF	splash10-0006-9000000000-ee83d5d19af792cc8783	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF	splash10-0006-9000000000-4faf1f04148279e9331a	2017-09-14	HMDB team, MONA	View Spectrum
Experimental LC-MS/MS	LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF	splash10-0006-9000000000-4b5d5bc4707cf980910e	2017-09-14	HMDB team, MONA	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 10V, Positive-QTOF	splash10-0a4i-0900000000-a715018533d6dc4e8052	2015-04-24	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 20V, Positive-QTOF	splash10-0a4i-1900000000-0370f837fa70b324ecfe	2015-04-24	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 40V, Positive-QTOF	splash10-0fc0-9000000000-f0196e420945b736f49b	2015-04-24	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 10V, Negative-QTOF	splash10-0a4i-0900000000-1000f1353d3e835b7498	2015-04-25	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 20V, Negative-QTOF	splash10-0a4i-0900000000-3b8b19ef01e3a1cb8a0d	2015-04-25	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - O-Toluidine 40V, Negative-QTOF	splash10-0a4i-9800000000-aecf80c0988d8154d1e9	2015-04-25	Wishart Lab	View Spectrum

NMR Spectra

Spectrum Type	Description	Deposition Date	Source	View
Predicted 1D NMR	¹H NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-24	Wishart Lab	View Spectrum

IR Spectra

Spectrum Type	Description	Deposition Date	Source	View
Predicted IR Spectrum	IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-)	2023-02-04	FELIX lab	View Spectrum
Predicted IR Spectrum	IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+)	2023-02-04	FELIX lab	View Spectrum
Predicted IR Spectrum	IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+)	2023-02-04	FELIX lab	View Spectrum

Biological Properties

Cellular Locations

Not Available

Biospecimen Locations

Not Available

Tissue Locations

Not Available

Pathways

Not Available

Name	SMPDB/PathBank	KEGG

Normal Concentrations

Not Available

Abnormal Concentrations

Not Available

Associated Disorders and Diseases

Disease References

None

Associated OMIM IDs

None

External Links

DrugBank ID

Not Available

Phenol Explorer Compound ID

Not Available

FooDB ID

KNApSAcK ID

Chemspider ID

KEGG Compound ID

BioCyc ID

Not Available

BiGG ID

Not Available

Wikipedia Link

Toluidine

METLIN ID

Not Available

PubChem Compound

7242

PDB ID

Not Available

ChEBI ID

66892

Food Biomarker Ontology

Not Available

VMH ID

Not Available

MarkerDB ID

Not Available

Good Scents ID

Not Available

References

Synthesis Reference

Not Available

Material Safety Data Sheet (MSDS)

Not Available

General References

Lawson NS, Haven GT, Moore TD: Long-term stability of glucose in lyophilized quality control serum. A study utilizing data from the Quality Assurance Service (QAS) Program of the College of American Pathologists. Am J Clin Pathol. 1978 Sep;70(3 Suppl):523-31. [PubMed:707419 ]
Roberts MC, Norman P: A re-evaluation of the D (+) xylose absorption test in the horse. Equine Vet J. 1979 Oct;11(4):239-43. [PubMed:540633 ]
Oganov RG, Aleksandrov AA, Vinogradova IV: [Sensitivity to insulin in acute myocardial infarct]. Kardiologiia. 1977 Jan;17(1):89-94. [PubMed:857071 ]
Preece MA, Newall RG: Dextrostix-Eyetone in the insulin hypoglycaemia test. Br Med J. 1977 Jul 16;2(6080):152-4. [PubMed:871822 ]
Kiang SW, Kuan JW, Kuan SS, Guilbault GG: Measurement of glucose in plasma, with use of immobilized glucose oxidase and peroxidase. Clin Chem. 1976 Aug;22(8):1378-82. [PubMed:949848 ]
Briggs TB, Smith RR: Exertional rhabdomyolysis associated with decerebrate posturing. Neurosurgery. 1986 Aug;19(2):297-9. [PubMed:3748364 ]
Akmal M, Massry SG: Peripheral nerve damage in patients with nontraumatic rhabdomyolysis. Arch Intern Med. 1983 Apr;143(4):835-6. [PubMed:6301396 ]
Schulze VE Jr: Rhabdomyolysis as a cause of acute renal failure. Postgrad Med. 1982 Dec;72(6):145-7, 150-8. [PubMed:7145778 ]
Ralph D: Rhabdomyolysis and acute renal failure. JACEP. 1978 Mar;7(3):103-6. [PubMed:633672 ]
Yasunaga Y, Nakanishi H, Naka N, Miki T, Tsujimura T, Itatani H, Okuyama A, Aozasa K: Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines. Lab Invest. 1997 Dec;77(6):677-84. [PubMed:9426406 ]
Viner BM, Kisel' VL, Krendal' FP, Rubtsova ER: [A modification of the ortho-toluidine method for determining glucose in the blood]. Eksp Klin Farmakol. 1993 May-Jun;56(3):62-4. [PubMed:8219998 ]
Line RL, Rust GS: Acute exertional rhabdomyolysis. Am Fam Physician. 1995 Aug;52(2):502-6. [PubMed:7625324 ]
De La Morena Garcia E, Garcia Lomas Pico LA, Salas Salas FJ, Cantero Garcia-Arenal L: [Comparison of the blood glucose levels obtained by the Reflomat-Glucose-Reflotest and the orthotoluidine method]. Rev Clin Esp. 1980 Mar 31;156(6):403-5. [PubMed:7394218 ]
Milne CJ: Rhabdomyolysis, myoglobinuria and exercise. Sports Med. 1988 Aug;6(2):93-106. [PubMed:3062736 ]
Sefer S, Degoricija V, Bilic B, Trotic R, Milanovic-Stipkovic B, Ratkovi-Gusic I, Kes P: Acute carbon monoxide poisoning as the cause of rhabdomyolysis and acute renal failure. Acta Med Croatica. 1999;53(4-5):199-202. [PubMed:10914136 ]
Tkaczewski W, Chojnacki J, Bogoniowska Z: The effect of glucagon on the blood levels of gastrin, insulin and glucose in patients with gastric and duodenal ulcers. Acta Hepatogastroenterol (Stuttg). 1979 Oct;26(5):396-8. [PubMed:525217 ]
Klimek K, Gdakowicz B, Gregorczyk J: [Ability of the tissues to assimilate glucose and the pyruvate and lactate levels after intravenous glucose load in patients with peripheral facial paralysis]. Neurol Neurochir Pol. 1985 Sep-Oct;19(5):395-400. [PubMed:3831793 ]
Polushina ND: [The effect of mineral water on serotonin and insulin production (an experimental study)]. Vopr Kurortol Fizioter Lech Fiz Kult. 1998 Jul-Aug;(4):9-10. [PubMed:9855765 ]
Varkonyi T, Balint GA, Csati S, Varro V: Laboratory method for measuring small amounts of tissue glycogen. Biochem Exp Biol. 1980;16(2):175-9. [PubMed:7348198 ]
Oganov RG, Aleksandrov AA, Vinogradova NV, Korochkin IM: [Content of immunoreactive insulin and catecholamines in blood plasma and disorders of carbohydrate metabolism in patients with myocardial infarct]. Kardiologiia. 1975 Sep;15(9):91-100. [PubMed:1230533 ]

Showing metabocard for O-Toluidine (HMDB0041965)

MOL for HMDB0041965 (O-Toluidine)

3D MOL for HMDB0041965 (O-Toluidine)

3D SDF for HMDB0041965 (O-Toluidine)

3D-SDF for HMDB0041965 (O-Toluidine)

PDB for HMDB0041965 (O-Toluidine)

3D PDB for HMDB0041965 (O-Toluidine)

SMILES for HMDB0041965 (O-Toluidine)

INCHI for HMDB0041965 (O-Toluidine)

Structure for HMDB0041965 (O-Toluidine)

3D Structure for HMDB0041965 (O-Toluidine)

Predicted Collision Cross Sections

Predicted Kovats Retention Indices

Underivatized

Derivatized

GC-MS Spectra

MS/MS Spectra

NMR Spectra

IR Spectra